Circassia Pharmaceuticals PLC Company Profile (LON:CIR)

About Circassia Pharmaceuticals PLC

Circassia Pharmaceuticals PLC logoCircassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates. Its next-generation immunotherapy is in Phase III testing for cat allergy. Its lead asthma treatment targets substitution of GlaxoSmithKline's (GSK's) Flixotide pMDI. It is developing therapies targeting direct substitution of Seretide pMDI and Serevent pMDI. The Company is also developing a range treatment, including a fixed dose triple combination containing an inhaled corticosteroid, long-acting beta agonist and long-acting muscarinic antagonist.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CIR
  • CUSIP:
Key Metrics:
  • Previous Close: $1.22
  • 50 Day Moving Average: $97.07
  • 200 Day Moving Average: $208.57
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $264.23B
  • Outstanding Shares: 284,778,000
Additional Links:

Analyst Ratings

Consensus Ratings for Circassia Pharmaceuticals PLC (LON:CIR) (?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: GBX 257.50

Analysts' Ratings History for Circassia Pharmaceuticals PLC (LON:CIR)
Show:
DateFirmActionRatingPrice TargetDetails
6/21/2016Barclays PLCInitiated CoverageOverweightGBX 410 -> GBX 170View Rating Details
6/21/2016Stifel NicolausDowngradeHoldView Rating Details
6/21/2016Royal Bank Of CanadaDowngradeSector PerformerGBX 430 -> GBX 105View Rating Details
6/21/2016JPMorgan Chase & Co.Lower Price TargetOverweightGBX 410 -> GBX 170View Rating Details
6/21/2016Peel HuntDowngradeAddGBX 509 -> GBX 160View Rating Details
6/20/2016Numis Securities LtdReiterated RatingUnder ReviewView Rating Details
5/18/2015Canaccord GenuityReiterated RatingBuyGBX 325View Rating Details
5/15/2015Shore CapitalReiterated RatingBuyView Rating Details
2/26/2015Oriel Securities LtdReiterated RatingAddGBX 320View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Circassia Pharmaceuticals PLC (LON:CIR)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Circassia Pharmaceuticals PLC (LON:CIR)
Current Year EPS Consensus Estimate: $-21.87 EPS

Dividends

Dividend History for Circassia Pharmaceuticals PLC (LON:CIR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Circassia Pharmaceuticals PLC (LON:CIR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2015Swingland,CharlesInsiderSell754,548GBX 320£2,414,553.60
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Circassia Pharmaceuticals PLC (LON:CIR)
DateHeadline
News IconRagweed allergy pipeline market report - identify diverse types of therapeutics under development, H2 2016 (LON:CIR)
www.whatech.com - August 16 at 4:17 PM
4-traders.com logoCircassia Pharmaceuticals : Notice of Results (LON:CIR)
www.4-traders.com - July 15 at 12:44 PM
News IconCVC hires Petty as partner and European healthcare head (LON:CIR)
www.pehub.com - July 14 at 4:19 PM
finanznachrichten.de logoGlobal Rhino-Conjunctivitis Therapeutics Report 2016 - Pipeline Review of 13 Companies & Drug Profile Activity - Research and Markets (LON:CIR)
www.finanznachrichten.de - July 12 at 4:21 PM
breakingfinancenews.com logoCantor Fitzgerald issued a report on (LON:CIR) Circassia Pharmaceuticals Plc, reducing its stock price target to 110GBX today (LON:CIR)
breakingfinancenews.com - July 11 at 4:10 PM
bizjournals.com logoIan Crosbie Joins Sequana Medical as Chief Financial Officer (LON:CIR)
www.bizjournals.com - July 11 at 9:03 AM
uk.finance.yahoo.com logoHas Brexit created the perfect opportunity to buy Woodford Patient Capital Trust plc? (LON:CIR)
uk.finance.yahoo.com - July 5 at 7:02 AM
News IconUS Company expert in Allergy Treatment affirms research fails to find hay fever treatment dose range (LON:CIR)
www.prcarbon.com - June 28 at 9:04 AM
ft.com logo[$$] Circassia's blemishes are a reminder of the risks in biotech (LON:CIR)
www.ft.com - June 26 at 7:48 AM
News IconCircassia Pharmaceuticals PLC (CIR) Downgraded to "Hold" at Stifel Nicolaus (LON:CIR)
expresioneconomica.org - June 22 at 8:56 AM
News IconCircassia's cat allergy drug fails to hit trial targets (LON:CIR)
newsnx.com - June 22 at 8:56 AM
breakingfinancenews.com logoCircassia Pharmaceuticals Plc (LON:CIR) price target lowered to GBX160 as covered today by Peel Hunt (LON:CIR)
breakingfinancenews.com - June 22 at 8:56 AM
4-traders.com logoFTSE supported by commodity stock rebound (LON:CIR)
www.4-traders.com - June 21 at 4:05 PM
breakingfinancenews.com logoCircassia Pharmaceuticals Plc (LON:CIR) stock price target reduced to GBX0 as announced today by Stifel (LON:CIR)
breakingfinancenews.com - June 21 at 4:05 PM
4-traders.com logoCircassia Pharmaceuticals : Reports Failure in Cat Allergy Trial (LON:CIR)
www.4-traders.com - June 20 at 10:34 AM
wsj.com logoCircassia Shares Plunge After Trial of Experimental Cat Allergy Drug Fails (LON:CIR)
www.wsj.com - June 20 at 10:34 AM
finance.yahoo.com logoCircassia Plunges as Cat-Allergy Treatment Fails Clinical Trial (LON:CIR)
finance.yahoo.com - June 20 at 10:34 AM
morningstar.co.uk logoCircassia Pharmaceuticals: "Dramatic" Placebo Effect In Allergy Study (LON:CIR)
www.morningstar.co.uk - June 20 at 10:34 AM
News IconCircassia's cat allergy treatment fails late-stage trial (LON:CIR)
www.channelnewsasia.com - June 20 at 10:34 AM
money.aol.co.uk logoWhy are Circassia Pharmaceuticals plc, Royal Bank of Scotland Group plc and McColl's Retail Group plc among today's major movers? (LON:CIR)
money.aol.co.uk - June 20 at 10:34 AM
proactiveinvestors.co.uk logoCircassia shares plummet as Phase III trials miss target (LON:CIR)
www.proactiveinvestors.co.uk - June 20 at 10:34 AM
breakingfinancenews.com logoCircassia Pharmaceuticals Plc (LON:CIR) price target held steady to GBX0 as announced today by Peel Hunt (LON:CIR)
breakingfinancenews.com - June 20 at 10:34 AM
bloomberg.com logoCircassia Falls Most Ever as Cat-Allergy Drug Fails in Trial (LON:CIR)
www.bloomberg.com - June 20 at 10:34 AM
capitalcube.com logoCircassia Pharmaceuticals Plc – Value Analysis (LONDON:CIR) : June 8, 2016 (LON:CIR)
www.capitalcube.com - June 8 at 1:37 PM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : CIR-GB : June 7, 2016 (LON:CIR)
www.capitalcube.com - June 7 at 4:40 AM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : CIR-GB : May 26, 2016 (LON:CIR)
www.capitalcube.com - May 26 at 4:36 AM
publicnow.com logoCircassia Initiates Grass Allergy Immunotherapy Registration Study (LON:CIR)
www.publicnow.com - May 25 at 2:26 AM
publicnow.com logoGrass Registration Study Initiation (LON:CIR)
www.publicnow.com - May 25 at 2:16 AM
publicnow.com logoGrant of awards to Directors (LON:CIR)
www.publicnow.com - May 19 at 11:02 AM
uk.finance.yahoo.com logoAre Royal Mail plc, AG Barr plc and Circassia Pharmaceuticals plc set to soar by 20%+? (LON:CIR)
uk.finance.yahoo.com - May 17 at 6:00 AM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : CIR-GB : May 11, 2016 (LON:CIR)
www.capitalcube.com - May 11 at 4:38 AM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : CIR-GB : April 18, 2016 (LON:CIR)
www.capitalcube.com - April 18 at 4:34 AM
capitalcube.com logoCircassia Pharmaceuticals Plc – Value Analysis (LONDON:CIR) : April 11, 2016 (LON:CIR)
www.capitalcube.com - April 11 at 3:22 PM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : CIR-GB : April 8, 2016 (LON:CIR)
www.capitalcube.com - April 8 at 4:34 AM
biz.yahoo.com logoFull Year 2015 Circassia Pharmaceuticals PLC Earnings Release - Time Not Supplied (LON:CIR)
biz.yahoo.com - March 11 at 7:07 AM
finance.yahoo.com logoChronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Global Pipeline Review, H2 2015 - Research and Markets (LON:CIR)
finance.yahoo.com - February 8 at 2:25 PM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : February 1, 2016 (LON:CIR)
www.capitalcube.com - February 1 at 4:37 AM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : January 19, 2016 (LON:CIR)
www.capitalcube.com - January 19 at 4:31 AM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : December 16, 2015 (LON:CIR)
www.capitalcube.com - December 16 at 4:31 AM
capitalcube.com logoCircassia Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : December 3, 2015 (LON:CIR)
www.capitalcube.com - December 3 at 4:33 AM
noodls.com logoCircassia Announces Positive Outcome of European Decentralised Procedure for Approval of Its Fluticasone Propionate Equivalent of GSK’s FLIXOTIDE® pMDI (LON:CIR)
www.noodls.com - November 24 at 2:43 AM
noodls.com logoCircassia’s Extended Offer Period for Aerocrine has Increased Acceptances to 97.2 Percent (LON:CIR)
www.noodls.com - August 17 at 11:33 AM
finance.yahoo.com logoCircassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 (LON:CIR)
finance.yahoo.com - June 3 at 9:00 AM
uk.finance.yahoo.com logoThe surprising success of Britain's university spin-outs (LON:CIR)
uk.finance.yahoo.com - May 30 at 12:00 PM
noodls.com logoProsonix to be acquired by Circassia Pharmaceuticals (LON:CIR)
www.noodls.com - May 15 at 3:19 AM
noodls.com logoGimv portfolio company Prosonix to be acquired by Circassia Pharmaceuticals (LON:CIR)
www.noodls.com - May 15 at 2:27 AM
noodls.com logoPreliminary Results for the Year Ended 31 December 2014 (LON:CIR)
www.noodls.com - February 26 at 2:50 AM
noodls.com logoCircassia Appoints Lota S Zoth as Non-Executive Director (LON:CIR)
www.noodls.com - February 9 at 10:33 PM

Social


Last Updated on 8/26/2016 by MarketBeat.com Staff